APO-PHARMAN
Timeline
27 events since 2007Board
Filings
Financial
Establishments
Address
Other
2008201020122014201620182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBabbreviated format · 9 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0892860848
Annual accounts 2024 filed PDFabbreviated format · 27 days late
2024
Highest result from 2009 to 2025 net €97,475 ▲20.6% The operating result of €135,386 and the net result of €97,475 are both a record.
Annual accounts 2023 filed PDFabbreviated format · 27 days late
2023
Registered office moved within AlveringemThe registered office moved from Dorp 30, 8690 Alveringem to Dorp 31, 8690 Alveringem · General meeting of 10-08-20234 points ▸
- General meeting, 10-08-2023
- Registered-office move, Dorp 31, 8690 Alveringem
- 100 shares
- Power of attorney,
- The deed holds 4 more points.
Annual accounts 2022 filed PDFabbreviated format · 29 days late
2022
Annual accounts 2021 filed PDFabbreviated format · 31 days late
2021
Back to profit net €8,687 The net result is €8,687, after 5 loss-making years.
Annual accounts 2020 filed PDFabbreviated format · 23 days late
2020
Annual accounts 2019 filed PDFabbreviated format · 31 days late
2019
Annual accounts 2018 filed PDFabbreviated format · 27 days before the deadline
2018
Weakest financial year net -€70,097 The net result drops to -€70,097, the lowest from 2009 to 2025. It recovers the following year.
Annual accounts 2017 filed PDFabbreviated format · 57 days late
2017
Annual accounts 2016 filed PDFabbreviated format · 31 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 30 days late
Algemene Vergadering - BoekjaarGeneral meeting of 24-03-20151 point ▸
- General meeting, 24-03-2015
- The deed holds 1 more point.
2014
Annual accounts 2014 filed PDFabbreviated format · 21 days late
2013
Annual accounts 2013 filed PDFabbreviated format · 22 days late
2012
Annual accounts 2012 filed PDFabbreviated format · 14 days late
Equity above €200,000 equity €220,375 ▲15.3% With a profit in every financial year since 2009, equity grows to €220,375.
2011
Annual accounts 2011 filed PDFabbreviated format · 30 days late
2010
Annual accounts 2010 filed PDFabbreviated format · 18 days before the deadline
Equity above €150,000 equity €168,964 ▲208% With a profit in every financial year since 2009, equity grows to €168,964.
2009
Annual accounts 2009 filed PDFabbreviated format · 1 day before the deadline
2007
Incorporation PDFpublished on 25-10-2007
First establishment APO PHARMAN BVBA, Dorp 31, Alveringem
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank